Floatz logo

Therapeutic Asset Ratings

1,055 results matching 1 filter

91,564 assets · 7,904 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Capmatinib
Neuroblastoma
Cancer Research UKP2/3CCC (50)
Capmatinib
Soft Tissue Sarcoma
Cancer Research UKP2/3CCC (50)
CEPHALOTAXINE 4-METHYL (2R)-2-HYDROXY-2-(4-HYDROXY-4-METHYLPENTYL)BUTANEDIOATE (ESTER)
Acute Lymphoblastic Leukemia
Institute of Hematology & Blood Diseases Hospital, ChinaP2/3CCC (50)
CLAVULANIC ACID
Leukemia
Monash UniversityP2/3CCC (50)
Deng Zhan Sheng Mai
Ischemic Stroke
Guangdong Provincial Hospital of Traditional Chinese MedicineP2/3CCC (50)
Fexofenadine
Parkinson Disease
Tanta UniversityP2/3CCC (50)
GEH300079 (68Ga)
Pancreatic Ductal Adenocarcinoma
GE HealthcareP2/3CCC (50)
Idarubicin Hydrochloride For
Hepatocellular Carcinoma
Zhongda HospitalP2/3CCC (50)
Iza-Bren
Breast Neoplasm
Bristol-Myers SquibbP2/3CCC (50)
jx10
Ischemic Stroke
Corxel PharmaceuticalsP2/3CCC (50)
Memantine
Hepatocellular Carcinoma
Inova Health Care ServicesP2/3CCC (50)
Montelukast
Parkinson Disease
Mostafa BahaaP2/3CCC (50)
Navlimetostat
Pancreatic Ductal Adenocarcinoma
Bristol-Myers SquibbP2/3CCC (50)
Neuroncell-Ex
Ischemic Stroke
Cytopeutics Sdn. Bhd.P2/3CCC (50)
ot-101
Pancreatic Ductal Adenocarcinoma
Oncotelic Inc.P2/3CCC (50)
Pegloxenatide
Obesity Disorder
Fudan UniversityP2/3CCC (50)
ro7771950
HER2 Positive Breast Carcinoma
Hoffmann-La RocheP2/3CCC (50)
Rulonilimab
Hepatocellular Carcinoma
Shandong New Time Pharmaceutical Co., LTDP2/3CCC (50)
SULFAMETHOXAZOLE
Leukemia
Monash UniversityP2/3CCC (50)
TEGAFUR
Pancreatic Ductal Adenocarcinoma
University of MalayaP2/3CCC (50)
Trimethoprim
Leukemia
Monash UniversityP2/3CCC (50)
Tucidinostat
Breast Neoplasm
Shengjing HospitalP2/3CCC (50)
Umbralisib
Follicular Lymphoma
City of Hope Medical CenterP2/3CCC (50)
VEMURAFENIB
Non-Small Cell Lung Carcinoma
Shanghai Kechow Pharma, Inc.P2/3CCC (50)
Vinpocetine
Parkinson Disease
Tanta UniversityP2/3CCC (50)
Showing 951 to 975 of 1,055 assets
PreviousPage 39 of 43Next